Immunogenicity and tolerability of COVID-19 vaccination in peritoneal dialysis patients-A prospective observational cohort study.

Michael HaasePaul LesnyAnja Haase-FielitzMark AndersonGavin ClohertyMichael StecCarlos LucasCarla Santos-AraujoMathias HaarhausFernando Macario

Published in: Seminars in dialysis (2021)

SARS-CoV-2 vaccination in COVID-19-naïve PD patients appeared to induce a very high rate of seroconversion but a substantially lower rate of patients with a strong response compared with medical personnel. Vaccination appeared to be safe in the PD patients studied.

Keyphrases

end stage renal disease
peritoneal dialysis
sars cov
chronic kidney disease
ejection fraction
newly diagnosed
coronavirus disease
healthcare
patient reported
respiratory syndrome coronavirus